Question 1

What is DARBEPOETIN ALFA used for?

Accepted Answer

DARBEPOETIN ALFA (brand name ARANESP) is a Other indicated for and upon initiation, there is a minimum of two additional months of planned chemotherapy ( 1.2 ). Limitations of Use Aranesp has not been shown to improve quality of life, fatigue.

Question 2

How does DARBEPOETIN ALFA work?

Accepted Answer

DARBEPOETIN ALFA works through the following mechanism: 12.1 Mechanism of Action Aranesp stimulates erythropoiesis by the same mechanism as endogenous erythropoietin..

Question 3

What are the most common side effects of DARBEPOETIN ALFA?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for DARBEPOETIN ALFA. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is DARBEPOETIN ALFA the same as ARANESP?

Accepted Answer

ARANESP is a brand name for DARBEPOETIN ALFA. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

DARBEPOETIN ALFA

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations